<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>GenAI Methods for Tumor Evolution and Early Detection | Cristea Lab</title>
    <link rel="stylesheet" href="../styles-warm-accent.css">
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <style>
        .research-page {
            margin-top: 100px;
            padding: 3rem 0;
        }
        .research-hero {
            background: linear-gradient(135deg, var(--primary-color), var(--secondary-color));
            color: white;
            padding: 4rem 0;
            text-align: center;
            margin-bottom: 4rem;
        }
        .research-hero h1 {
            font-size: 3rem;
            margin-bottom: 1rem;
        }
        .research-hero p {
            font-size: 1.3rem;
            max-width: 800px;
            margin: 0 auto;
            opacity: 0.9;
        }
        .research-section {
            margin-bottom: 4rem;
        }
        .research-section h2 {
            font-size: 2.5rem;
            color: var(--primary-color);
            margin-bottom: 2rem;
            border-bottom: 3px solid var(--primary-color);
            padding-bottom: 0.5rem;
        }
        .project-card {
            background: white;
            border-radius: 15px;
            box-shadow: var(--shadow);
            padding: 2.5rem;
            margin-bottom: 2rem;
            border-left: 5px solid var(--accent-color);
            transition: var(--transition);
        }
        .project-card:hover {
            transform: translateY(-5px);
            box-shadow: 0 15px 35px rgba(0, 0, 0, 0.15);
        }
        .project-card h3 {
            font-size: 1.8rem;
            color: var(--primary-color);
            margin-bottom: 1rem;
        }
        .project-card h4 {
            font-size: 1.3rem;
            color: var(--accent-color);
            margin-bottom: 1rem;
            font-weight: 600;
        }
        .project-description {
            font-size: 1.1rem;
            line-height: 1.7;
            margin-bottom: 1.5rem;
        }
        .project-details {
            background: var(--bg-light);
            padding: 1.5rem;
            border-radius: 10px;
            margin: 1.5rem 0;
        }
        .project-details h5 {
            color: var(--primary-color);
            margin-bottom: 1rem;
        }
        .methodology-list {
            list-style: none;
            padding: 0;
        }
        .methodology-list li {
            padding: 0.5rem 0;
            border-bottom: 1px solid #eee;
        }
        .methodology-list li:last-child {
            border-bottom: none;
        }
        .methodology-list li::before {
            content: 'ðŸ”¬';
            margin-right: 0.5rem;
        }
        .impact-highlight {
            background: linear-gradient(135deg, #f8f9fa, #e9ecef);
            padding: 2rem;
            border-radius: 15px;
            border-left: 5px solid var(--secondary-color);
            margin: 2rem 0;
        }
        .impact-highlight h4 {
            color: var(--secondary-color);
            margin-bottom: 1rem;
        }
        .collaboration-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 1.5rem;
            margin: 2rem 0;
        }
        .collaborator {
            background: white;
            padding: 1.5rem;
            border-radius: 10px;
            box-shadow: var(--shadow);
            text-align: center;
        }
        .tech-stack {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin: 1rem 0;
        }
        .tech-tag {
            background: var(--primary-color);
            color: white;
            padding: 0.3rem 0.8rem;
            border-radius: 15px;
            font-size: 0.9rem;
            font-weight: 500;
        }
        .figure-container {
            background: white;
            padding: 2rem;
            border-radius: 15px;
            box-shadow: var(--shadow);
            margin: 2rem 0;
            text-align: center;
        }
        .figure-container img {
            max-width: 100%;
            height: auto;
            border-radius: 10px;
        }
        .figure-caption {
            font-style: italic;
            color: var(--text-light);
            margin-top: 1rem;
            font-size: 0.95rem;
        }
        .clinical-urgency {
            background: linear-gradient(135deg, #ffebee, #ffcdd2);
            padding: 2rem;
            border-radius: 15px;
            border-left: 5px solid #f44336;
            margin: 2rem 0;
        }
        .clinical-urgency h4 {
            color: #d32f2f;
            margin-bottom: 1rem;
        }
        .ehr-data-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 1.5rem;
            margin: 2rem 0;
        }
        .data-type-card {
            background: white;
            padding: 1.5rem;
            border-radius: 10px;
            box-shadow: var(--shadow);
            border-top: 4px solid var(--accent-color);
            text-align: center;
        }
        .challenge-highlight {
            background: linear-gradient(135deg, #fff3e0, #ffe0b2);
            padding: 2rem;
            border-radius: 15px;
            border-left: 5px solid #ff9800;
            margin: 2rem 0;
        }
        .challenge-highlight h4 {
            color: #f57c00;
            margin-bottom: 1rem;
        }
        .validation-pipeline {
            background: linear-gradient(135deg, #e8f5e8, #c8e6c9);
            padding: 2rem;
            border-radius: 15px;
            border-left: 5px solid #4caf50;
            margin: 2rem 0;
        }
        .validation-pipeline h4 {
            color: #2e7d32;
            margin-bottom: 1rem;
        }
        .milestones-timeline {
            position: relative;
            margin: 2rem 0;
        }
        .milestones-timeline::before {
            content: '';
            position: absolute;
            left: 20px;
            top: 0;
            bottom: 0;
            width: 2px;
            background: var(--primary-color);
        }
        .milestone-item {
            position: relative;
            padding-left: 60px;
            margin-bottom: 2rem;
            background: white;
            padding: 1.5rem;
            border-radius: 10px;
            box-shadow: var(--shadow);
            margin-left: 40px;
        }
        .milestone-item::before {
            content: '';
            position: absolute;
            left: -49px;
            top: 20px;
            width: 18px;
            height: 18px;
            background: var(--primary-color);
            border-radius: 50%;
            border: 4px solid white;
            box-shadow: 0 0 0 4px var(--primary-color);
        }
        .milestone-date {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--primary-color);
            margin-bottom: 0.5rem;
        }
    </style>
</head>
<body>
    <!-- Navigation -->
    <nav class="navbar">
        <div class="nav-container">
            <div class="nav-brand">
                <h1>Cristea Lab</h1>
                <span class="nav-subtitle">AI Cancer Genomics Research</span>
            </div>
            <ul class="nav-menu">
                <li><a href="../index.html" class="nav-link">Home</a></li>
                <li><a href="../index.html#research" class="nav-link">Research</a></li>
                <li><a href="../team.html" class="nav-link">Team</a></li>
                <li><a href="../publications.html" class="nav-link">Publications</a></li>
                <li><a href="../index.html#software" class="nav-link">Software</a></li>
                <li><a href="../index.html#contact" class="nav-link">Contact</a></li>
            </ul>
            <div class="nav-toggle">
                <span class="bar"></span>
                <span class="bar"></span>
                <span class="bar"></span>
            </div>
        </div>
    </nav>

    <!-- Research Page Content -->
    <div class="research-page">
        <!-- Hero Section -->
        <div class="research-hero">
            <div class="container">
                <h1>GenAI Methods for Tumor Evolution and Early Detection</h1>
                <p>
                    Pioneering the application of Large Language Models and generative AI to understand cancer progression patterns 
                    and enable early detection through electronic health records, revolutionizing both basic cancer biology research 
                    and clinical decision-making.
                </p>
            </div>
        </div>

        <div class="container">
            <!-- Overview -->
            <div class="research-section">
                <h2>Research Overview</h2>
                <div class="project-description">
                    Our lab is at the forefront of developing and applying Generative AI and Large Language Models (LLMs) to tackle 
                    two critical challenges in cancer research: understanding tumor evolution at the single-cell level and enabling 
                    early detection of pancreatic cancer through electronic health record analysis. By treating genomic data as a 
                    language and leveraging transformer architectures, we are creating powerful tools that can both predict cancer 
                    progression patterns and identify high-risk patients years before clinical symptoms appear.
                </div>
                
                <div class="impact-highlight">
                    <h4>Dual Impact: Basic Science and Clinical Translation</h4>
                    <p>
                        This integrated research program represents a paradigm shift in cancer genomics, combining foundational 
                        advances in understanding tumor evolution with practical clinical applications for early detection. Our 
                        LLM-based approaches enable zero-shot prediction of cancer progression, mechanistic interpretability of 
                        tumor biology, and the potential to dramatically improve patient outcomes through early intervention.
                    </p>
                </div>
            </div>

            <!-- Part 1: Tumor Evolution with LLMs -->
            <div class="research-section">
                <h2>Part I: LLMs for Tumor Evolution</h2>
                
                <!-- evoCancerGPT -->
                <div class="project-card">
                    <h3>evoCancerGPT - Zero-shot Cancer Evolution</h3>
                    <div class="project-description">
                        evoCancerGPT is our flagship large language model specifically designed to understand and generate cancer 
                        evolutionary trajectories. Using a decoder-only transformer architecture, the model can predict the next 
                        steps in cancer progression given initial cellular states, treating cancer evolution as a narrative that 
                        can be both understood and predicted.
                    </div>

                    <div class="figure-container">
                        <div style="background: #f8f9fa; padding: 3rem; border-radius: 10px; border: 2px dashed var(--primary-color);">
                            <i class="fas fa-chart-line" style="font-size: 4rem; color: var(--primary-color); margin-bottom: 1rem;"></i>
                            <p style="color: var(--primary-color); font-weight: 600;">evoCancerGPT Architecture Diagram</p>
                            <p style="font-size: 0.9rem; color: var(--text-light);">Decoder-only transformer with MLP layers for sparse expression matrices</p>
                        </div>
                        <div class="figure-caption">
                            Figure: Overview of evoCancerGPT architecture showing data preprocessing pipeline, sentence construction 
                            from 4096 tokens representing cells in pseudotime order, and transformer architecture with extra MLP layers 
                            to handle sparse scRNA-seq data and non-linear relationships.
                        </div>
                    </div>

                    <div class="project-details">
                        <h5>Model Architecture</h5>
                        <ul class="methodology-list">
                            <li>Decoder-only transformer with 4096 token context length</li>
                            <li>Evolutionary sentences constructed in increasing pseudotime order</li>
                            <li>Extra MLP layers before and after transformer blocks</li>
                            <li>Specialized handling of sparse expression matrices</li>
                            <li>Zero-shot generation capabilities for unseen cancer types</li>
                        </ul>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">GPT Architecture</span>
                        <span class="tech-tag">Pseudotime Analysis</span>
                        <span class="tech-tag">Zero-shot Learning</span>
                        <span class="tech-tag">Cancer Evolution</span>
                        <span class="tech-tag">scRNA-seq</span>
                    </div>
                </div>

                <!-- Multi-modal Foundation Models -->
                <div class="project-card">
                    <h3>Multi-modal Foundation Models for Genomics</h3>
                    <div class="project-description">
                        We are developing the next generation of foundation models that can simultaneously process and integrate 
                        multiple types of genomic data - transcriptomics, proteomics, and epigenomics - within a unified transformer 
                        architecture. This multi-modal approach enables comprehensive understanding of tumor biology.
                    </div>
                    
                    <div class="project-details">
                        <h5>Technical Approach</h5>
                        <ul class="methodology-list">
                            <li>Multi-modal transformer architecture with cross-attention mechanisms</li>
                            <li>Custom tokenization strategies for different omics data types</li>
                            <li>Self-supervised pre-training on large-scale cancer genomics datasets</li>
                            <li>Fine-tuning for downstream tasks including drug response prediction</li>
                            <li>Handling missing modalities common in clinical settings</li>
                        </ul>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">PyTorch</span>
                        <span class="tech-tag">Transformers</span>
                        <span class="tech-tag">Multi-modal Learning</span>
                        <span class="tech-tag">Single-cell RNA-seq</span>
                        <span class="tech-tag">Proteomics</span>
                    </div>
                </div>

                <!-- Clinical Trial Applications -->
                <div class="project-card">
                    <h3>Foundation Models for Clinical Trial Data</h3>
                    <div class="project-description">
                        We evaluate and apply state-of-the-art foundation models like scGPT to real-world single nucleus RNA 
                        sequencing data from ongoing clinical trials at the Hale Center for Pancreatic Cancer. This work bridges 
                        the gap between research models and clinical applications.
                    </div>

                    <div class="project-details">
                        <h5>Clinical Trial Integration</h5>
                        <ul class="methodology-list">
                            <li>Analysis of Paricalcitol clinical trial data (Vitamin D receptor agonist)</li>
                            <li>Pre-treatment and post-treatment single nucleus RNA sequencing</li>
                            <li>Foundation model fine-tuning on clinical genomics data</li>
                            <li>Biomarker discovery for treatment response prediction</li>
                            <li>Integration with clinical outcome data</li>
                        </ul>
                    </div>

                    <div class="figure-container">
                        <div style="background: #f8f9fa; padding: 3rem; border-radius: 10px; border: 2px dashed var(--accent-color);">
                            <i class="fas fa-hospital" style="font-size: 4rem; color: var(--accent-color); margin-bottom: 1rem;"></i>
                            <p style="color: var(--accent-color); font-weight: 600;">Clinical Trial Workflow</p>
                            <p style="font-size: 0.9rem; color: var(--text-light);">Paricalcitol trial with pre/post treatment analysis</p>
                        </div>
                        <div class="figure-caption">
                            Overview of the Paricalcitol clinical trial conducted at the Hale Center, evaluating the effect of 
                            Paricalcitol (vitamin D receptor agonist) combined with gemcitabine and albumin-bound paclitaxel 
                            in metastatic pancreatic cancer patients.
                        </div>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">scGPT</span>
                        <span class="tech-tag">Clinical Genomics</span>
                        <span class="tech-tag">Biomarker Discovery</span>
                        <span class="tech-tag">Treatment Response</span>
                        <span class="tech-tag">snRNA-seq</span>
                    </div>
                </div>

                <!-- RLHF Enhancement -->
                <div class="project-card">
                    <h3>Reinforcement Learning Enhanced LLMs</h3>
                    <div class="project-description">
                        We implement reinforcement learning from human feedback (RLHF) techniques to improve LLM performance 
                        on single cell genomics tasks, particularly cell type annotation. This approach, inspired by our 
                        collaboration with DeepSeek-R1, enhances model reasoning capabilities.
                    </div>

                    <div class="project-details">
                        <h5>Reinforcement Learning Framework</h5>
                        <ul class="methodology-list">
                            <li>Human feedback integration for cell type annotation quality</li>
                            <li>Reward model training based on expert biological knowledge</li>
                            <li>Policy optimization for improved reasoning chains</li>
                            <li>Multi-step reasoning for complex cell state identification</li>
                            <li>Continuous learning from expert corrections</li>
                        </ul>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">RLHF</span>
                        <span class="tech-tag">DeepSeek-R1</span>
                        <span class="tech-tag">Cell Type Annotation</span>
                        <span class="tech-tag">Reasoning Models</span>
                        <span class="tech-tag">Expert Knowledge</span>
                    </div>
                </div>
            </div>

            <!-- Part 2: Early Detection with LLMs -->
            <div class="research-section">
                <h2>Part II: LLMs for Early Cancer Detection</h2>
                
                <div class="clinical-urgency">
                    <h4>The Pancreatic Cancer Early Detection Challenge</h4>
                    <p>
                        Pancreatic cancer has a 5-year survival rate of only 12%, primarily because 80% of patients are 
                        diagnosed at advanced stages when surgical resection is no longer possible. Early detection could 
                        dramatically improve outcomes, as patients diagnosed at early stages have survival rates approaching 
                        70%. Our LLM-based approach to analyzing electronic health records could identify high-risk patients 
                        1-3 years before clinical diagnosis.
                    </p>
                </div>

                <!-- EHR Data Resources -->
                <div class="project-card">
                    <h3>Mass Gen-Brigham-Dana Farber Electronic Health Records</h3>
                    <div class="project-description">
                        We have access to electronic health records from 1 million patients in the Mass Gen-Brigham-Dana 
                        Farber medical system, representing one of the largest and most comprehensive healthcare datasets 
                        available for pancreatic cancer research. This dataset includes decades of patient interactions 
                        across multiple healthcare settings.
                    </div>

                    <div class="ehr-data-grid">
                        <div class="data-type-card">
                            <i class="fas fa-notes-medical" style="font-size: 2rem; color: var(--primary-color); margin-bottom: 1rem;"></i>
                            <h4>Clinical Notes</h4>
                            <p>Physician notes, radiology reports, pathology reports</p>
                        </div>
                        <div class="data-type-card">
                            <i class="fas fa-vial" style="font-size: 2rem; color: var(--primary-color); margin-bottom: 1rem;"></i>
                            <h4>Laboratory Results</h4>
                            <p>Blood tests, tumor markers, metabolic panels</p>
                        </div>
                        <div class="data-type-card">
                            <i class="fas fa-x-ray" style="font-size: 2rem; color: var(--primary-color); margin-bottom: 1rem;"></i>
                            <h4>Imaging Studies</h4>
                            <p>CT, MRI, ultrasound reports and findings</p>
                        </div>
                        <div class="data-type-card">
                            <i class="fas fa-pills" style="font-size: 2rem; color: var(--primary-color); margin-bottom: 1rem;"></i>
                            <h4>Medications</h4>
                            <p>Prescriptions, dosages, treatment histories</p>
                        </div>
                        <div class="data-type-card">
                            <i class="fas fa-procedures" style="font-size: 2rem; color: var(--primary-color); margin-bottom: 1rem;"></i>
                            <h4>Procedures</h4>
                            <p>Surgical procedures, endoscopies, biopsies</p>
                        </div>
                        <div class="data-type-card">
                            <i class="fas fa-heartbeat" style="font-size: 2rem; color: var(--primary-color); margin-bottom: 1rem;"></i>
                            <h4>Vital Signs</h4>
                            <p>Weight, blood pressure, symptom tracking</p>
                        </div>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">Electronic Health Records</span>
                        <span class="tech-tag">1M Patients</span>
                        <span class="tech-tag">Longitudinal Data</span>
                        <span class="tech-tag">Multi-modal</span>
                        <span class="tech-tag">Real-world Evidence</span>
                    </div>
                </div>

                <!-- LLM Methodology for EHR -->
                <div class="project-card">
                    <h3>Adapting Foundation Models for EHR Analysis</h3>
                    <div class="project-description">
                        Led by Dr. Jifan Gao (joining June 2025), we are developing novel Large Language Model 
                        architectures specifically designed for electronic health record analysis. This work builds 
                        on recent breakthroughs in medical AI while addressing the unique challenges of pancreatic 
                        cancer early detection.
                    </div>

                    <div class="project-details">
                        <h5>Technical Innovation</h5>
                        <ul class="methodology-list">
                            <li>Adaptation of transformer architectures for temporal medical data</li>
                            <li>Multi-modal integration of text, numerical, and imaging data</li>
                            <li>Attention mechanisms for long-term temporal relationships</li>
                            <li>Handling missing and incomplete data in real-world settings</li>
                            <li>Privacy-preserving training methods for sensitive health data</li>
                        </ul>
                    </div>

                    <div class="challenge-highlight">
                        <h4>Real-World Data Challenges</h4>
                        <p>
                            Unlike previous research that used heavily curated datasets, our work addresses the 
                            challenges of real-world clinical data including missing values, inconsistent formatting, 
                            varying data quality, and the need to handle data from multiple healthcare systems with 
                            different practices and documentation standards.
                        </p>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">Large Language Models</span>
                        <span class="tech-tag">Transformer Architecture</span>
                        <span class="tech-tag">Multi-modal AI</span>
                        <span class="tech-tag">Temporal Modeling</span>
                        <span class="tech-tag">Privacy-Preserving AI</span>
                    </div>
                </div>

                <!-- Clinical Decision Support -->
                <div class="project-card">
                    <h3>Clinical Decision Support Integration</h3>
                    <div class="project-description">
                        Our early detection system is designed as a clinical decision support tool that can be 
                        integrated into routine healthcare workflows. The system will provide risk scores and 
                        recommendations to clinicians during regular patient encounters, enabling proactive 
                        screening and intervention.
                    </div>

                    <div class="validation-pipeline">
                        <h4>Clinical Validation Pipeline</h4>
                        <p>
                            The project will culminate in a prospective clinical trial to evaluate how our AI system 
                            performs in real-world settings when deployed to help clinicians identify high-risk patients. 
                            This validation study will assess not only diagnostic accuracy but also clinical utility, 
                            physician acceptance, and patient outcomes.
                        </p>
                    </div>

                    <div class="project-details">
                        <h5>Implementation Considerations</h5>
                        <ul style="list-style-type: disc; padding-left: 2rem;">
                            <li><strong>User Interface Design</strong> - Intuitive dashboards for busy clinicians</li>
                            <li><strong>Alert Fatigue Prevention</strong> - Calibrated thresholds to minimize false positives</li>
                            <li><strong>Explainable AI</strong> - Clear reasoning for risk assessments</li>
                            <li><strong>Privacy and Security</strong> - HIPAA-compliant implementation</li>
                            <li><strong>Continuous Monitoring</strong> - Performance tracking and model updates</li>
                        </ul>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">Clinical Decision Support</span>
                        <span class="tech-tag">EHR Integration</span>
                        <span class="tech-tag">Real-time Analysis</span>
                        <span class="tech-tag">Explainable AI</span>
                        <span class="tech-tag">Clinical Validation</span>
                    </div>
                </div>
            </div>

            <!-- Research Timeline -->
            <div class="research-section">
                <h2>Project Timeline & Milestones</h2>
                <div class="project-card">
                    <h3>Integrated 5-Year Research Plan</h3>
                    <div class="project-description">
                        This comprehensive research program spans multiple phases, from foundational model development 
                        through clinical validation, with parallel tracks for tumor evolution understanding and early 
                        detection implementation.
                    </div>

                    <div class="milestones-timeline">
                        <div class="milestone-item">
                            <div class="milestone-date">Year 1 (2025-2026)</div>
                            <h4>Foundation & Baseline</h4>
                            <p>Deploy evoCancerGPT for tumor evolution studies, validate existing early detection methodologies 
                               on institutional dataset, and establish baseline performance metrics for both research tracks.</p>
                        </div>
                        <div class="milestone-item">
                            <div class="milestone-date">Year 2 (2026-2027)</div>
                            <h4>Algorithm Development & Integration</h4>
                            <p>Develop multi-modal foundation models for genomics, create novel LLM architectures for EHR analysis, 
                               and integrate clinical trial data with evolution models.</p>
                        </div>
                        <div class="milestone-item">
                            <div class="milestone-date">Year 3 (2027-2028)</div>
                            <h4>Validation & Optimization</h4>
                            <p>Extensive validation of both tumor evolution predictions and early detection algorithms, 
                               implement RLHF enhancements, and develop clinical decision support interfaces.</p>
                        </div>
                        <div class="milestone-item">
                            <div class="milestone-date">Year 4 (2028-2029)</div>
                            <h4>Clinical Integration</h4>
                            <p>Pilot deployment of early detection system in clinical settings, integrate evolution insights 
                               into treatment planning, and collect prospective validation data.</p>
                        </div>
                        <div class="milestone-item">
                            <div class="milestone-date">Year 5 (2029-2030)</div>
                            <h4>Prospective Clinical Trials</h4>
                            <p>Large-scale clinical trials for early detection system, validation of evolution-based treatment 
                               strategies, and establishment of new standards for AI in cancer care.</p>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Key Publications & Software -->
            <div class="research-section">
                <h2>Publications & Software</h2>
                <div class="project-card">
                    <h3>Key Outputs</h3>
                    <div class="project-details">
                        <h5>Recent Publications</h5>
                        <ul style="list-style-type: disc; padding-left: 2rem;">
                            <li><strong>Tan et al.</strong> "Evaluating and Interpreting scGPT: a Foundation Model for Single-Cell Biology in Real-World Cancer Clinical Trial Data" - AACR Pancreatic Cancer 2024</li>
                            <li><strong>evoCancerGPT manuscript</strong> - In preparation for Nature Methods submission 2025</li>
                            <li><strong>Multi-modal foundation models review</strong> - Contributing to comprehensive survey paper</li>
                            <li><strong>Early detection methodology</strong> - Building on Placido et al. Nature Medicine 2023</li>
                        </ul>
                    </div>

                    <div class="project-details">
                        <h5>Software & Tools</h5>
                        <ul style="list-style-type: disc; padding-left: 2rem;">
                            <li><strong>evoCancerGPT</strong> - Open-source implementation with pre-trained models</li>
                            <li><strong>Clinical LLM Pipeline</strong> - Tools for applying foundation models to clinical data</li>
                            <li><strong>Multi-modal Genomics Toolkit</strong> - Integration framework for omics data</li>
                            <li><strong>EHR Analysis Framework</strong> - Privacy-preserving tools for health record analysis</li>
                        </ul>
                    </div>
                </div>
            </div>

            <!-- Research Team -->
            <div class="research-section">
                <h2>Research Team & Collaborations</h2>
                
                <div class="project-card">
                    <h3>Team Leadership</h3>
                    <div class="project-description">
                        Our interdisciplinary team combines expertise in machine learning, computational biology, clinical 
                        oncology, and translational medicine. Dr. Jifan Gao will join in June 2025 as a postdoctoral fellow 
                        to lead the early detection initiative, bringing expertise in large language models for healthcare.
                    </div>
                    
                    <div class="collaboration-grid">
                        <div class="collaborator">
                            <h4>Hale Center Teams</h4>
                            <p>Dr. Brian Wolpin, Dr. Andrew Aguirre, Dr. Jonathan Nowak</p>
                        </div>
                        <div class="collaborator">
                            <h4>Broad Institute</h4>
                            <p>AI/ML and Genomics Platform collaborations</p>
                        </div>
                        <div class="collaborator">
                            <h4>Industry Partners</h4>
                            <p>DeepSeek AI, leading tech companies</p>
                        </div>
                        <div class="collaborator">
                            <h4>Clinical Teams</h4>
                            <p>Mass Gen-Brigham-Dana Farber oncology departments</p>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Expected Impact -->
            <div class="research-section">
                <h2>Expected Impact & Future Directions</h2>
                <div class="impact-highlight">
                    <h4>Transforming Cancer Care Through AI</h4>
                    <p>
                        Our integrated approach to cancer AI research bridges the gap between basic science and clinical 
                        application. By developing LLMs that can both understand tumor evolution and enable early detection, 
                        we are creating a comprehensive framework for AI-driven cancer care. This work has the potential to:
                    </p>
                    <ul style="list-style-type: disc; padding-left: 2rem; margin-top: 1rem;">
                        <li>Increase pancreatic cancer survival rates from 12% to potentially 50-70% through early detection</li>
                        <li>Enable personalized treatment strategies based on predicted tumor evolution patterns</li>
                        <li>Establish new standards for AI integration in cancer research and clinical care</li>
                        <li>Create generalizable frameworks applicable to other cancer types and diseases</li>
                        <li>Position the Hale Center as a global leader in AI-driven cancer genomics</li>
                    </ul>
                </div>

                <div class="validation-pipeline">
                    <h4>Next Phase Developments</h4>
                    <p>
                        We are expanding our GenAI capabilities to include mechanistic interpretability methods, 
                        reinforcement learning enhancements, and multi-institutional collaborations. Future work will 
                        focus on creating a unified AI platform that seamlessly integrates tumor evolution insights 
                        with clinical decision-making, ultimately transforming how we understand, detect, and treat cancer.
                    </p>
                </div>
            </div>

            <!-- Back Navigation -->
            <div class="text-center" style="margin-top: 3rem;">
                <a href="../index.html#research" class="btn btn-secondary">Back to Research Overview</a>
            </div>
        </div>
    </div>

    <!-- Footer -->
    <footer class="footer">
        <div class="container">
            <div class="footer-content">
                <div class="footer-logo">
                    <h3>Cristea Lab</h3>
                    <p>AI Cancer Genomics Research</p>
                </div>
                <div class="footer-links">
                    <a href="https://www.dana-farber.org" target="_blank">Dana-Farber Cancer Institute</a>
                    <a href="https://www.harvard.edu" target="_blank">Harvard University</a>
                </div>
                <div class="footer-social">
                    <a href="#" class="social-link"><i class="fab fa-twitter"></i></a>
                    <a href="#" class="social-link"><i class="fab fa-github"></i></a>
                    <a href="#" class="social-link"><i class="fab fa-linkedin"></i></a>
                </div>
            </div>
            <div class="footer-bottom">
                <p>&copy; 2024 Cristea Lab. All rights reserved.</p>
            </div>
        </div>
    </footer>

    <script src="../script.js"></script>
</body>
</html>